Synthesis of Rocaglamide Hydroxamates and Related Compounds as Eukaryotic Translation Inhibitors: Synthetic and Biological Studies
- 30 November 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (1), 558-562
- https://doi.org/10.1021/jm201263k
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Design and synthesis of potent Gram-negative specific LpxC inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- Novel Flavaglines Displaying Improved CytotoxicityJournal of Medicinal Chemistry, 2010
- Biomimetic Photocycloaddition of 3‐Hydroxyflavones: Synthesis and Evaluation of Rocaglate Derivatives as Inhibitors of Eukaryotic TranslationAngewandte Chemie-International Edition, 2010
- Gold‐Catalyzed Halogenation of Aromatics by N‐HalosuccinimidesAngewandte Chemie-International Edition, 2010
- Total Synthesis of the Potent Anticancer Aglaia Metabolites (−)-Silvestrol and (−)-Episilvestrol and the Active Analogue (−)-4′-DesmethoxyepisilvestrolJournal of the American Chemical Society, 2009
- Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma modelJCI Insight, 2008
- Enantioselective Synthesis of the Complex Rocaglate (−)‐SilvestrolAngewandte Chemie-International Edition, 2007
- Design and Evaluation of Hydroxamate Derivatives as Metal-Mediated Inhibitors of a Protein Tyrosine KinaseJournal of Medicinal Chemistry, 2006
- Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4ANature Chemical Biology, 2006
- General Reactivity of 2-Lithiobenzothiazole to Various Electrophiles and the Use as a Formyl Anion Equivalent in the Synthesis of α-Hydroxy Carbonyl CompoundsBulletin of the Chemical Society of Japan, 1988